Search for Current Clinical Trials

Study Name Description Trial Category Trial SubCategory
A021703 Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS) Cancer Gastrointestinal
A031501 Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation Cancer Bladder/Urothelial
A031803 Phase II Trial of Intravesical Gemcitabine and MK-3475 (pembrolizumab) in the Treatment of Patients with BCG-Unresponseve Non-Muscle Invasive Bladder Cancer Cancer Bladder
A041702 Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (= 70 Years of Age) Cancer Hematology
A061202 A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib VS. Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Relapsing on Lenalidomide as Part of First Line Therapy Cancer Multiple Myeloma
AALL08B1 Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) Childhood Cancers Leukemia
AALL0932 Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL) Childhood Cancers Leukemia
AALL1231 A Phase lll Randomized Trial Investigating Bortezomib (NSC#681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy) Childhood Cancers Leukemia
AALL1521 A Phase 2 study of the JAK1/JAK2 Inhibitor Ruxolitinib with Chemotherapy in Children with De Novo High-Risk CRLF2 Rearranged and/ or JAK Pathway-Mutant Acute Lymphoblastic Leukemia Childhood Cancers Leukemia
Acoustic Diagnosis of Gastroesophageal Reflux Disease Baby/Child Reflux Disease
ANBL1232 Utilizing Response-and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High Risk Neuroblastoma Childhood Cancers Blastoma
APEC14B1 EveryChild A Registry, Eligibility Screening, Biology and Outcome Study Childhood Cancers Registry
Champion AF The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation. Heart & Vascular Atrial Fibrillation
COG-AALL05B1 Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens Childhood Cancers Leukemia
COG-AALL1331 Risk Stratified Randomized Phase lll Testing of blinatumomab (IND#117467, NCS#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) Childhood Cancers Leukemia
COG-ACNS0332 Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other than Average Risk Medulloblastoma/PNET Patients Childhood Cancers Blastoma
COG-ACNS0831 Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years Childhood Cancers Glioma
COG-AEWS07B1 A Children's Oncology Group Protocol for Collecting and Banking Ewing Sarcoma Specimens Childhood Cancers Sarcoma
COG-AHEP0731 Treatment of Children with All Stages of Hepatoblastoma Childhood Cancers Blastoma
COG-AHOD1331 A randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND # 117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents Childhood Cancers Lymphoma
COG-ANBL00B1 Neuroblastoma Biology Studies Childhood Cancers Blastoma
COG-AREN03B2 Renal Tumors Classification, Biology, and Banking Study Childhood Cancers Tumor
COG: ARST1321 Pazopanib Neoadjuvant triao in Non-Rhabdomyosarcoma soft tissue sarcomas(PAZNTIS): A phase II/III randomized trial preoperative chemoradiation or preop radiation plus or minus Pazopanib Childhood Cancers Sarcoma
COG:ACNS1123 Phase 2 trial of response based radiation therapy for patients with localized central nervous system Germ Cel Tumors Childhood Cancers Tumor
Crest 2 Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial IDE G130221 Heart & Vascular Cardiac Disease
E4512 A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib vs. Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK+) Fusion Protein (ALCHEMIST)(Sub-Study of A151216) Cancer Lung
EA2165 Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer Cancer Gastrointestinal
EA3132 Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing Cancer Head and Neck
EA3161 A Phase II/III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA Cancer Head and Neck
EA5163: INSIGNA: A Randomized Phase III Study of First-line Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Post-progression in Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC) with Immuno-biomarker SIGNature-driven Analysis Cancer Lung